Aspergillus spp. cause morbidity and mortality in immunocompromised hosts (6, 9, 15, 18, 21, 23, 27, 28, 34) . Fusarium spp. are emerging pathogens resistant to amphotericin B in immunocompromised patients (1, 2, 24) . This genus contains important toxigenic species causing several human and animal diseases (2, 16, 19, 29, 36) .
The identification of naturally occurring fungicidal compounds without toxicity for mammalian cells would be beneficial. The cecropin family of lytic peptides may prove useful. Cecropins form large pores in bacterial cell membranes causing lysis but lack lethality for mammalian cells (4, 5, 14, 17, 30, 33) . Cecropin A (CA), consisting of 37 amino acids, complexes with lipopolysaccharide (3, 8) . Little is known, however, about the antifungal activity of CA. We, therefore, studied CA fungicidal activity and binding sites for five Aspergillus and Fusarium isolates.
Antifungal activity against nongerminated and germinating conidia. Aspergillus flavus, Aspergillus fumigatus, Aspergillus niger, Fusarium moniliforme, and Fusarium oxysporum were grown on potato dextrose agar (PDA; Difco, Detroit, Mich.) slants (7 days, 30ЊC). Conidia were harvested in 1% potato dextrose broth (PDB; Difco). Conidial suspensions (10 4 /ml) were incubated for 8 h (30ЊC) to obtain germinating conidia (7) . Nongerminated conidia (10 4 conidia/ml) were used immediately. Separate assays determined CA (Sigma Chemical Co., St. Louis, Mo.) fungicidal activity against nongerminated and germinating conidia. CA stock solutions (1 g/l) were freshly prepared with 1% PDB. Control samples consisted of 45 l of conidia plus 405 l of 1% PDB. Test samples composed of conidia (45 l), the appropriate volume of stock CA, and 1% PDB (total volume, 450 l) were mixed and incubated (30 min, 30ЊC). Sample aliquots (50 l) were spread on each of 8 PDA plates and incubated (30ЊC, 24 h), and colonies were enumerated.
MICs by microwell assays. Fungal inhibition was studied (10, 11) by a standardized microdilution assay with MOPS (morpholinepropanesulfonic acid)-buffered (pH 7.0) RPMI medium plus glutamine (BioWhittaker, Inc., Walkersville, Md.). In addition, separate MIC assays in 1% PDB were performed to study the effect of PDB. Duplicate wells contained 20 l of sample having 10 4 conidia/ml with suitable amounts of stock CA and 1% PDB (final volume, 200 l). Plates were shaken gently (5 min) and incubated (30ЊC, 96 h). MIC was defined as the lowest concentration having no visible growth in both wells (22) . The minimal lethal concentration (MLC) was determined as described previously (35) . Extraction and identification of conidial wall compounds. All fungi were grown on PDA in Roux flasks (7 days at 30ЊC). Conidia were harvested with sterile 0.05% Triton X-100, passed through four layers of double cheesecloth, washed three times in sterile water, and freeze-dried. Germinated conidia were obtained by incubating (8 h, 30ЊC) freeze-dried conidia (0.3 g) in 20 ml of 1% PDB with occasional agitation; conidia were washed three times, freeze-dried, and stored at 0ЊC.
Nongerminated and germinating conidia (0.3 g) were extracted once (5 min) with 15 ml of high-pressure liquid chromatography (HPLC)-grade (J. T. Baker Chemical Co., Phillipsburg, N.J.) hexane or chloroform-methanol (2:1 [vol/vol]). After centrifugation, supernatants were passed through sintered glass filters and reduced to 100 l with N 2 . Samples (1 l) were analyzed by gas chromatography-mass spectrometry in the electron ionization mode.
Sedimentation analysis of ergosterol and cholesterol binding to CA. Free ergosterol or cholesterol was mixed with CA (0.17 and 2.0 M final concentrations, respectively) in phosphate-buffered saline with 0.05% peroxide-free Tween 20. Controls contained CA (2.0 M). Triplicate samples were incubated (2 h, 37ЊC) and centrifuged (7,000 ϫ g, 15 min, 4ЊC). Supernatants were analyzed in triplicate for unbound CA (32) .
Fluorescent microscopy. Conidia also were studied (13) by using CA tagged with fluorescein isothiocyanate (CA-FL; Sigma). Nongerminating conidia and hyphae of F. moniliforme and germinating conidia of A. flavus were observed for complexing with CA-FL. Conidial controls were observed in parallel.
CA degradation. Suspensions (250 l) of washed and unwashed nongerminated or germinated conidia of A. flavus (10 6 /ml in 1% PDB) were added to CA (100 g), and the mixtures were mixed and incubated (30ЊC, 30 min). Controls (100 g of CA in 250 l of 1% PDB), nongerminated conidia (10 6 /ml in 1% PDB), and germinating conidia (10 6 /ml in 1% PDB) were incubated similarly. Slant culture supernatants of A. flavus and unwashed nongerminated and germinating conidia of F. moniliforme were also incubated with CA. To timed samples was added 10% trifluoroacetic acid (1:10 [vol/ vol]). CA and its breakdown products were analyzed by HPLC.
Statistical analysis.
Viable count bioassays were performed on three occasions. Analysis of variance and the least significant difference test were performed on the data. Data were pooled by sample type (n ϭ 24). A 95% level of significance was employed.
Determination of antifungal activity by viable count bioassay. CA had fungicidal activity against germinating Aspergillus species conidia (Fig. 1) . The susceptibility of Aspergillus spp. to CA was in the following order (least susceptible to most susceptible): A. flavus, A. niger, A. fumigatus. CA was not lethal to nongerminated conidia of Aspergillus. CA was lethal at concentrations as low as 0.5 M for both nongerminated and germinating conidia of both Fusarium species (Fig. 2) , with F. moniliforme slightly more susceptible than F. oxysporum. Hexane and chloroform-methanol extracts of fungal conidia. Nongerminated and germinated conidia of Aspergillus spp. and F. oxysporum contained ergosterol. Cholesterol was observed in nongerminated conidia of F. moniliforme. Germinated conidia of F. moniliforme contained only ergosterol.
MIC and MLCs. MICs and MLCs in buffered RPMI
Ergosterol and cholesterol binding to CA. Soluble CA in the CA-ergosterol and CA-cholesterol mixtures was reduced by 43.4 and 41.8%, respectively, as compared to the level in the CA control. The results indicated that binding occurred between CA and these sterols.
Fluorescent microscopy. Nongerminated F. moniliforme conidia and hyphae were observed to brightly fluoresce when treated with CA-FL (Fig. 3) . Lethality was dependent on genus, species, and conidial stage. CA-FL bound to germinating but not to nongerminating A. flavus conidia, suggesting that the conidial wall was changing during hyphal formation, thus offering binding sites to CA unavailable on nongerminating conidia. Ergosterol, present in conidia of A. flavus, complexed with CA. By comparison, CA complexed with ergosterol in both conidial and hyphal elements of Fusarium spp., which is consistent with the antifungal activity of CA against nongerminated and germinating fusarial conidia.
Freshly harvested conidial suspensions and culture supernatant samples of A. flavus degraded CA. Unwashed, germinating conidial samples of A. flavus only weakly degraded CA, suggesting that protease activity was lost during incubation. Washed nongerminated and germinating conidia in A. flavus samples had no proteolytic activity, indicating the presence of an extracellular protease. F. moniliforme did not degrade CA.
The fungicidal activity of CA against filamentous fungi was validated in two systems. Unlike antifungal azoles, which are fungistatic, CA is fungicidal under standard in vitro conditions. CA fungicidal activity is more analogous to that of amphotericin B against Aspergillus spp. CA was effective against nongerminated and germinated conidia of the Fusarium spp. The identification of fungicidal agents against Fusarium spp. is especially important, as there are no commercially available agents other than amphotericin B with in vitro antifungal activity against Fusarium spp. (26). In addition to its potential as a systemic agent, CA could be useful as a topical agent for treatment of Aspergillus and Fusarium keratitis (31) . Since its fungicidal activity is rapid, CA may prevent irreparable corneal tissue damage. Research has demonstrated that cecropins can be safely administered to animals to combat cancer and bacterial infection (12, 20, 25) .
